Tau Aggregation: Genomics

Tau aggregation is an important characteristic in some neurodegenerative disorders, including Alzheimer’s Disease. Discover the latest research using genomics to understand Tau aggregation.

February 28, 2021
Open Access

Exome-wide age-of-onset analysis reveals exonic variants in ERN1 and SPPL2C associated with Alzheimer's disease.

Translational Psychiatry
Liang HeAlzheimer’s Disease Neuroimaging Initiative
February 28, 2021
Review

MECP2 and the Biology of MECP2 Duplication Syndrome.

Journal of Neurochemistry
Santosh R D'Mello
February 23, 2021

Clinical and neuropathological variability in the rare IVS10 + 14 tau mutation.

Neurobiology of Aging
Selena P MaxwellSultan Darvesh
February 21, 2021
Open Access

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease.

Acta Neuropathologica
Emma GerritsErik W G M Boddeke
February 21, 2021
Open Access

Gut flora-targeted photobiomodulation therapy improves senile dementia in an Aß-induced Alzheimer's disease animal model.

Journal of Photochemistry and Photobiology. B, Biology
Qianqian ChenJichun Yang
February 14, 2021

Genetic study of young-onset dementia using targeted gene panel sequencing in Taiwan.

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
Jung-Lung HsuTa-Fu Chen
February 13, 2021
Open Access

Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's disease.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Young Won KimOlivier Lichtarge
February 12, 2021

Association of Mitochondrial DNA Genomic Variation with Risk of Pick's disease.

Neurology
Rebecca R ValentinoOwen A Ross
February 5, 2021

Genetics of frontotemporal dementia in China.

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Yaling JiangLu Shen
February 2, 2021
Open Access

Molecular subtyping of Alzheimer's disease using RNA sequencing data reveals novel mechanisms and targets.

Science Advances
Ryan A NeffBin Zhang
January 28, 2021
Review
Open Access

Genetic Factors That Could Affect Concussion Risk in Elite Rugby.

Sports
Mark R AntrobusAlun G Williams
January 21, 2021
Review
Open Access

Unravelling Genetic Factors Underlying Corticobasal Syndrome: A Systematic Review.

Cells
Federica ArientiAlessio Di Fonzo
January 15, 2021
Open Access

AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.

Alzheimer's Research & Therapy
Yadi ZhouFeixiong Cheng
January 13, 2021
Open Access

Molecular characterization of selectively vulnerable neurons in Alzheimer's disease.

Nature Neuroscience
Kun LengMartin Kampmann
January 13, 2021
Review

Clinical and Neuroimaging Aspects of Familial Frontotemporal Lobar Degeneration Associated with MAPT and GRN Mutations.

Advances in Experimental Medicine and Biology
Bradley F Boeve, Howard Rosen
January 13, 2021

Tau Protein and Frontotemporal Dementias.

Advances in Experimental Medicine and Biology
Michel GoedertBernardino Ghetti
January 13, 2021

A Multi-omics Data Resource for Frontotemporal Dementia Research.

Advances in Experimental Medicine and Biology
Peter HeutinkAnupriya Dalmia

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/tau-aggregation-genomics/dd022db5-6b6e-48b7-a623-82e481dc12ef